Patient

Patients need more guidance on chemo web information

Doctors and nurses may be underestimating the value placed on internet chemotherapy information by cancer patients and missing out on opportunities to discuss this information with them, new research finds today. Doctors and nurses may be underestimating the value placed on internet chemotherapy information by cancer patients and missing out on opportunities to discuss this information with them, new research finds today.

15 February 2012

Cancer Research UK launches translation service

Cancer Research UK's cancer information nurses are launching a translation service. Cancer Research UK's cancer information nurses are launching a translation service.

21 January 2010

People looking for information on cancer say variety is key

PEOPLE looking for detailed information about cancer outside of hospitals need a range of different information sources, reveals a Cancer Research UK survey published in the November issue of Cancer Nursing Practice*. PEOPLE looking for detailed information about cancer outside of hospitals need a range of different information sources, reveals a Cancer Research UK survey published in the November issue of Cancer Nursing Practice*.

18 November 2009

• Health & Medicine

Confusing leaflets put patients off medication

Patients could stop taking their medicine if the risks of possible side effects are not clearly explained - says a study published in the British Journal of Health Pyschology. Patients could stop taking their medicine if the risks of possible side effects are not clearly explained - says a study published in the British Journal of Health Pyschology.

10 August 2009

• Health & Medicine

New research sheds light on ways to improve treatment for aggressive breast cancer

Changing the order that chemotherapy drugs are given to breast cancer patients before surgery makes treatment much more effective, according to trial results presented at the American Society of Clinical Oncology (ASCO) conference, today. Changing the order that chemotherapy drugs are given to breast cancer patients before surgery makes treatment much more effective, according to trial results presented at the American Society of Clinical Oncology (ASCO) conference, today.

29 May 2009

• Health & Medicine

Bowel cancer screening to be considered from age 25 for high risk group

CANCER RESEARCH UK-funded scientists have discovered that a genetic marker can be used to identify relatives of bowel cancer patients who are much more likely to develop the disease than the general population. The research suggests that for these families with an unusually high risk, screening for bowel cancer might be needed from the age of 25, while for those without the marker it is safe to start screening later. The study is published today in the Journal of Clinical Oncology*. CANCER RESEARCH UK-funded scientists have discovered that a genetic marker can be used to identify relatives of bowel cancer patients who are much more likely to develop the disease than the general population. The research suggests that for these families with an unusually high risk, screening for bowel cancer might be needed from the age of 25, while for those without the marker it is safe to start screening later. The study is published today in the Journal of Clinical Oncology*.

23 March 2009

Molecular test for cancer relapse in UK children

A molecular marker used in America to predict whether children with a form of kidney cancer, called Wilms' tumour, are more likely to relapse than other children, could be useful for UK patients. The study is published in the European Journal of Cancer* today (Wednesday). A molecular marker used in America to predict whether children with a form of kidney cancer, called Wilms' tumour, are more likely to relapse than other children, could be useful for UK patients. The study is published in the European Journal of Cancer* today (Wednesday).

4 March 2009

• Health & Medicine

Blood test clue for lung cancer treatment

CANCER RESEARCH UK-funded scientists have identified a new molecular marker in blood which could indicate how patients with a type of lung cancer will respond to treatment, according to research published in Clinical Cancer Research*. CANCER RESEARCH UK-funded scientists have identified a new molecular marker in blood which could indicate how patients with a type of lung cancer will respond to treatment, according to research published in Clinical Cancer Research*.

1 January 2009

'Intelligent' cancer drug development boosts success rates

A NEW ERA of intelligent cancer drug development has spurred a leap in the proportion of drugs reaching patients, according to a study by Cancer Research UK scientists published in Nature Reviews Drug Discovery*. A NEW ERA of intelligent cancer drug development has spurred a leap in the proportion of drugs reaching patients, according to a study by Cancer Research UK scientists published in Nature Reviews Drug Discovery*.

14 November 2008

Women risk their lives by failing to take breast cancer drugs

Breast cancer patients are risking their lives by failing to take the tamoxifen they are prescribed, according to a new study published in the British Journal of Cancer* today (Tuesday). Breast cancer patients are risking their lives by failing to take the tamoxifen they are prescribed, according to a new study published in the British Journal of Cancer* today (Tuesday).

4 November 2008

• Health & Medicine

Side effects predict succes of breast cancer treatment

Hot flushes, night sweats and painful joints can be a blessing in disguise for breast cancer patients - according to a new report published online today in Lancet Oncology. Hot flushes, night sweats and painful joints can be a blessing in disguise for breast cancer patients - according to a new report published online today in Lancet Oncology.

30 October 2008

• Health & Medicine

Therapy reduces death from anal cancer by a third

A CANCER RESEARCH UK trial has shown anal cancer patients who received a different form of treatment were a third less likely to die in the long term from anal cancer, according to long-term survival data presented at the National Cancer Research Institute (NCRI) Cancer Conference, today (Tuesday). A CANCER RESEARCH UK trial has shown anal cancer patients who received a different form of treatment were a third less likely to die in the long term from anal cancer, according to long-term survival data presented at the National Cancer Research Institute (NCRI) Cancer Conference, today (Tuesday).

7 October 2008